Beatrice Bortesi

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino, Nadia Naldi, Beatrice Bortesi et al. · Journal of Clinical Oncology · 2008 · 955 citations · Full text

Medicine, Immunology, Oncology +17

Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification

Michael T. Parsons, Emma Tudini, Hongyan Li et al. · Human Mutation · 2019 · 152 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Antonino Musolino, Maria Angela Bella, Beatrice Bortesi et al. · The Breast · 2007 · 133 citations

Medicine, Genetics, Molecular Genetics +17

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations

Marcello Tiseo, Francesco Gelsomino, Daniela Boggiani et al. · Lung Cancer · 2010 · 126 citations

Medicine, Genetics, Oncology +17

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy

Roberta Minari, Paola Bordi, Marzia Del Re et al. · Lung Cancer · 2017 · 108 citations

Medicine, Pathology, Pharmacotherapy +11